# PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression

> **NCT06289517** · NA · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** 68Ga-Her2-affibody

## Key facts

- **NCT ID:** NCT06289517
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-05-28
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-08-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06289517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06289517, "PET Imaging of 68Ga-Her2-affibody in Tumors with High Her2 Expression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06289517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*